title: Antagonism of LPS and IFN-gamma induced iNOS expression in human atrial endothelia by morphine, anandamide, and estrogen.
abstract: OBJECTIVE
  To determine whether inducible nitric oxide synthase (iNOS) stimulation of human atrial fragments can be diminished by the naturally occurring signal molecules, such as morphine, anandamide, and estrogen. The use of iNOS as an indicator is justified since it has been associated with initiation of various types of cellular damage either directly or indirectly.
  
  
  METHODS
  Western blots were performed on control and drug-exposed atrial tissue before and after lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) exposure.
  
  
  RESULTS
  Preincubation of the tissue with morphine, anandamide or estrogen prior to, but not after, the addition of LPS + IFN-gamma, blocked iNOS expression. The nitric oxide donor SNAP also blocked iNOS induction while preincubation of atrial fragments with an inhibitor of NOS, L-NAME, prior to morphine or anandamide exposure, restored LPS + IFN-gamma induction of iNOS.
  
  
  CONCLUSIONS
  These data suggest a direct regulatory link at the transcriptional level between constitutive (c) NOS and iNOS in human atrial tissue.
authors.affiliation: Neuroscience Research Institute, State University of New York, College at Old Westbury, Old Westbury, NY 11568, USA.
authors.forename: C
authors.initials: C
authors.lastname: Fimiani
authors.forename: H
authors.initials: H
authors.lastname: Magazine
authors.forename: I D
authors.initials: ID
authors.lastname: Welters
authors.forename: T V
authors.initials: TV
authors.lastname: Bilfinger
authors.forename: F
authors.initials: F
authors.lastname: Salsano
authors.forename: E
authors.initials: E
authors.lastname: Tonnesen
authors.forename: G B
authors.initials: GB
authors.lastname: Stefano
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000701:Analgesics, Opioid / Q000494:pharmacology*; D001095:Arachidonic Acids / Q000494:pharmacology*; D063388:Endocannabinoids; D004727:Endothelium / Q000201:enzymology; D004958:Estradiol / Q000494:pharmacology*; D006325:Heart Atria / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000037:antagonists & inhibitors; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors; D009020:Morphine / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II; D053284:Polyunsaturated Alkamides
chemical_list: D000276:Adjuvants, Immunologic; D000701:Analgesics, Opioid; D001095:Arachidonic Acids; D063388:Endocannabinoids; D008070:Lipopolysaccharides; D053284:Polyunsaturated Alkamides; D004958:Estradiol; D009020:Morphine; D007371:Interferon-gamma; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C078814:anandamide